1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Long Acting Drug Delivery Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Device
1.2.3 Parenteral Injections
1.3 Market by Application
1.3.1 Global Long Acting Drug Delivery Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Specialty Clinics
1.3.4 Clinical Research Institutes
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Long Acting Drug Delivery Market Perspective (2017-2028)
2.2 Long Acting Drug Delivery Growth Trends by Region
2.2.1 Long Acting Drug Delivery Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Long Acting Drug Delivery Historic Market Size by Region (2017-2022)
2.2.3 Long Acting Drug Delivery Forecasted Market Size by Region (2023-2028)
2.3 Long Acting Drug Delivery Market Dynamics
2.3.1 Long Acting Drug Delivery Industry Trends
2.3.2 Long Acting Drug Delivery Market Drivers
2.3.3 Long Acting Drug Delivery Market Challenges
2.3.4 Long Acting Drug Delivery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Long Acting Drug Delivery Players by Revenue
3.1.1 Global Top Long Acting Drug Delivery Players by Revenue (2017-2022)
3.1.2 Global Long Acting Drug Delivery Revenue Market Share by Players (2017-2022)
3.2 Global Long Acting Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Long Acting Drug Delivery Revenue
3.4 Global Long Acting Drug Delivery Market Concentration Ratio
3.4.1 Global Long Acting Drug Delivery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Long Acting Drug Delivery Revenue in 2021
3.5 Long Acting Drug Delivery Key Players Head office and Area Served
3.6 Key Players Long Acting Drug Delivery Product Solution and Service
3.7 Date of Enter into Long Acting Drug Delivery Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Long Acting Drug Delivery Breakdown Data by Type
4.1 Global Long Acting Drug Delivery Historic Market Size by Type (2017-2022)
4.2 Global Long Acting Drug Delivery Forecasted Market Size by Type (2023-2028)
5 Long Acting Drug Delivery Breakdown Data by Application
5.1 Global Long Acting Drug Delivery Historic Market Size by Application (2017-2022)
5.2 Global Long Acting Drug Delivery Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Long Acting Drug Delivery Market Size (2017-2028)
6.2 North America Long Acting Drug Delivery Market Size by Country (2017-2022)
6.3 North America Long Acting Drug Delivery Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Long Acting Drug Delivery Market Size (2017-2028)
7.2 Europe Long Acting Drug Delivery Market Size by Country (2017-2022)
7.3 Europe Long Acting Drug Delivery Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Long Acting Drug Delivery Market Size (2017-2028)
8.2 Asia-Pacific Long Acting Drug Delivery Market Size by Country (2017-2022)
8.3 Asia-Pacific Long Acting Drug Delivery Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Long Acting Drug Delivery Market Size (2017-2028)
9.2 Latin America Long Acting Drug Delivery Market Size by Country (2017-2022)
9.3 Latin America Long Acting Drug Delivery Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Long Acting Drug Delivery Market Size (2017-2028)
10.2 Middle East & Africa Long Acting Drug Delivery Market Size by Country (2017-2022)
10.3 Middle East & Africa Long Acting Drug Delivery Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 ViiV Healthcare
11.1.1 ViiV Healthcare Company Detail
11.1.2 ViiV Healthcare Business Overview
11.1.3 ViiV Healthcare Long Acting Drug Delivery Introduction
11.1.4 ViiV Healthcare Revenue in Long Acting Drug Delivery Business (2017-2022)
11.1.5 ViiV Healthcare Recent Development
11.2 Halozyme Therapeutics
11.2.1 Halozyme Therapeutics Company Detail
11.2.2 Halozyme Therapeutics Business Overview
11.2.3 Halozyme Therapeutics Long Acting Drug Delivery Introduction
11.2.4 Halozyme Therapeutics Revenue in Long Acting Drug Delivery Business (2017-2022)
11.2.5 Halozyme Therapeutics Recent Development
11.3 Lubrizol Life Science
11.3.1 Lubrizol Life Science Company Detail
11.3.2 Lubrizol Life Science Business Overview
11.3.3 Lubrizol Life Science Long Acting Drug Delivery Introduction
11.3.4 Lubrizol Life Science Revenue in Long Acting Drug Delivery Business (2017-2022)
11.3.5 Lubrizol Life Science Recent Development
11.4 Celanese Corporation
11.4.1 Celanese Corporation Company Detail
11.4.2 Celanese Corporation Business Overview
11.4.3 Celanese Corporation Long Acting Drug Delivery Introduction
11.4.4 Celanese Corporation Revenue in Long Acting Drug Delivery Business (2017-2022)
11.4.5 Celanese Corporation Recent Development
11.5 Kashiv BioSciences
11.5.1 Kashiv BioSciences Company Detail
11.5.2 Kashiv BioSciences Business Overview
11.5.3 Kashiv BioSciences Long Acting Drug Delivery Introduction
11.5.4 Kashiv BioSciences Revenue in Long Acting Drug Delivery Business (2017-2022)
11.5.5 Kashiv BioSciences Recent Development
11.6 4P Therapeutics
11.6.1 4P Therapeutics Company Detail
11.6.2 4P Therapeutics Business Overview
11.6.3 4P Therapeutics Long Acting Drug Delivery Introduction
11.6.4 4P Therapeutics Revenue in Long Acting Drug Delivery Business (2017-2022)
11.6.5 4P Therapeutics Recent Development
11.7 Ipsen
11.7.1 Ipsen Company Detail
11.7.2 Ipsen Business Overview
11.7.3 Ipsen Long Acting Drug Delivery Introduction
11.7.4 Ipsen Revenue in Long Acting Drug Delivery Business (2017-2022)
11.7.5 Ipsen Recent Development
11.8 Midatech Pharma
11.8.1 Midatech Pharma Company Detail
11.8.2 Midatech Pharma Business Overview
11.8.3 Midatech Pharma Long Acting Drug Delivery Introduction
11.8.4 Midatech Pharma Revenue in Long Acting Drug Delivery Business (2017-2022)
11.8.5 Midatech Pharma Recent Development
11.9 Re-Vana Therapeutics
11.9.1 Re-Vana Therapeutics Company Detail
11.9.2 Re-Vana Therapeutics Business Overview
11.9.3 Re-Vana Therapeutics Long Acting Drug Delivery Introduction
11.9.4 Re-Vana Therapeutics Revenue in Long Acting Drug Delivery Business (2017-2022)
11.9.5 Re-Vana Therapeutics Recent Development
11.10 Creative Biolabs
11.10.1 Creative Biolabs Company Detail
11.10.2 Creative Biolabs Business Overview
11.10.3 Creative Biolabs Long Acting Drug Delivery Introduction
11.10.4 Creative Biolabs Revenue in Long Acting Drug Delivery Business (2017-2022)
11.10.5 Creative Biolabs Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
